Marie-Eve Hamelin
Overview
Explore the profile of Marie-Eve Hamelin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talah S, Carbonneau J, Hamelin M, Gilca R, Boivin G
J Med Virol
. 2024 Nov;
96(11):e70054.
PMID: 39531249
We looked at the interactions between viral loads, coinfection rates and disease severity for children infected with two pneumoviruses: human metapneumovirus (HMPV) and respiratory syncytial virus (RSV). The HMPV RNA...
2.
Charland K, Quach C, Papenburg J, Pierce L, Nguyen C, Saucier A, et al.
Vaccine
. 2024 Nov;
43(Pt 1):126489.
PMID: 39489137
Background: Given the growing evidence on the benefits of hybrid immunity, continued monitoring of vaccine uptake is warranted, particularly of socio-demographic subgroups with early vaccine hesitancy. Racial/ethnic and lower income...
3.
Charland K, Pierce L, Saucier A, Hamelin M, Barbosa Da Torre M, Carbonneau J, et al.
Epidemiol Infect
. 2024 Sep;
152:e103.
PMID: 39320472
Since early 2022, routine testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on symptoms and exposure history has largely ceased in Canada. Consequently, seroprevalence studies, particularly longitudinal studies,...
4.
Charland K, Pannunzio M, Greenspan-Ardman E, Saucier A, Pierce L, Hamelin M, et al.
BMJ Open
. 2024 Aug;
14(8):e081838.
PMID: 39182934
Objectives: To assess the seroprevalence of infection-acquired SARS-CoV-2 and the mental health of school/daycare staff in the months after reopening of schools in Montreal, Quebec (Canada) in the Fall of...
5.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, et al.
NPJ Vaccines
. 2024 Jul;
9(1):125.
PMID: 38982077
No abstract available.
6.
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, et al.
NPJ Vaccines
. 2024 Jun;
9(1):111.
PMID: 38898106
Live-Attenuated Vaccines (LAVs) stimulate robust mucosal and cellular responses and have the potential to protect against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV), the main etiologic agents of viral...
7.
Ghesquiere L, Boivin G, Demuth B, Giguere Y, Forest J, Hamelin M, et al.
J Obstet Gynaecol Can
. 2023 Nov;
46(4):102291.
PMID: 38000624
Objectives: COVID-19 has been associated with preterm birth (PTB) and placental-mediated complications, including fetal growth restriction and preeclampsia (PE). This study aimed to estimate the impact of COVID-19 and vaccination...
8.
Zinszer K, Charland K, Pierce L, Saucier A, Hamelin M, Barbosa Da Torre M, et al.
Influenza Other Respir Viruses
. 2023 Aug;
17(8):e13186.
PMID: 37638094
The EnCORE study is a prospective serology study of SARS-CoV-2 in a cohort of children from Montreal, Canada. Based on data from our fourth round of data collection (May-October 2022),...
9.
Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin M, et al.
Int J Infect Dis
. 2023 Mar;
131:119-126.
PMID: 36963656
Objectives: To use serological testing to assess the pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies in children and adolescents in Montréal, Canada. Design: This analysis is from a...
10.
Cote F, Bestman-Smith J, Gourdeau M, Simpson S, Hamelin M, Carbonneau J, et al.
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
7(3):283-291.
PMID: 36337604
Background: COVID-19 is usually a time-limited disease. However, prolonged infections and reinfections can occur among immunocompromised patients. It can be difficult to distinguish a prolonged infection from a new one,...